<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03098758</url>
  </required_header>
  <id_info>
    <org_study_id>CIRPT_AL2017_1</org_study_id>
    <nct_id>NCT03098758</nct_id>
  </id_info>
  <brief_title>Molecular Analysis in Peritoneal Washing Citology for Locally Advanced Gastric Cancer</brief_title>
  <official_title>Pilot Study of Comparative Molecular Analysis CK20, CEA and BER-EP4 in Peritoneal Washing Citology for Locally Advanced Gastric Cancer and Their Ability to Predict Peritoneal Dissemination</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric carcinoma is a disease with a high mortality. Peritoneal washing cytology has a
      recognized prognostic utility. However sensibility of this study is not appropriate. Studies
      with PCR (polymerase chain retrotranscription) can increase sensibility and accurate staging
      information.

      Objective: To analyze the sensibility and specificity of the expression of CK20, CEA and
      Ber-EP4 with PCR technique in peritoneal washings of advanced gastric carcinoma without
      clinical evidence of peritoneal carcinomatosis.

      Methodology: Retrotranscription analysis (RT-PCR) and quantitative PCR (qPCR) of CK20, CEA
      and Ber-EP4 in peritoneal washing. Test the feasibility of qPCR with this new marker
      (Ber-EP4). Comparison of the results with data obtained with conventional cytology. Study of
      peritoneal recurrence.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 8, 2017</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>specific markers in peritoneal cells</measure>
    <time_frame>during surgical intervention</time_frame>
    <description>Detection of CK20, CEA and BER-EP4 by PCR technique in peritoneal washing of advanced gastric cancer</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Polymerase Chain Reaction</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      gastric cancer cells in peritoneal washing
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with advanced gastric cancer without macroscopic peritoneal carcinomatosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with resectable advanced gastric cancer

          -  Informed consent

        Exclusion Criteria:

          -  Macroscopic peritoneal carcinomatosis

          -  Non operable patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexis Luna, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Corporación Parc Taulí</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexis Luna, MD PhD</last_name>
    <phone>0034937231010</phone>
    <phone_ext>21458</phone_ext>
    <email>Aluna@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Parc Tauli Hospital Universitari</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Alexis Luna</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>Polymerase Chain Reaction</keyword>
  <keyword>gastric cancer</keyword>
  <keyword>citology</keyword>
  <keyword>peritoneal washing</keyword>
  <keyword>CK20</keyword>
  <keyword>CEA</keyword>
  <keyword>BER-EP4</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

